11:46 AM EST - Theralase Technologies Inc. : Announced today that the U.S. Food and Drug Administration has granted 510(k) approval for Theralase’s next generation therapeutic laser, the TLC-2000 Therapeutic Medical Laser System. Theralase Technologies Inc.
shares V.TLT are trading up $0.035 at $0.33.
